-
How Does Mylan's $300 EpiPen Compare To Other Generics?
Friday, December 16, 2016 - 2:26pm | 425Read More...Mylan NV (NASDAQ: MYL) faced its fair share of controversy earlier this year for increasing the price of its potentially life-saving EpiPen product by more than 400 percent over the past few years. On Friday, Mylan announced the launch of the authorized generic for EpiPen at a wholesale acquisition...
-
Have You Heard About This Generic EpiPen Maker?
Wednesday, August 24, 2016 - 9:01am | 376Read More...Mylan NV (NASDAQ: MYL) is the latest pharmaceutical company to come under government scrutiny. Mylan is the maker of a device that provides epinephrine in the event of anaphylaxis — also known as the EpiPen. According to Fortune, Mylan built the EpiPen from a "weakening enterprise" in 2007 to...
-
Teva Says Its Generic EpiPen Will Be 'Significantly Delayed'
Tuesday, March 1, 2016 - 2:53pm | 229Read More...Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) announced in a regulatory filing on Monday that it has received notice from the U.S. Food and Drug Administration (FDA) related to its epinephrine. Teva said that the FDA identified "certain major deficiencies" and now expects its epinephrine...
